Jefferies Initiates Coverage On Biohaven with Buy Rating, Announces Price Target of $57
Portfolio Pulse from Benzinga Newsdesk
Jefferies has initiated coverage on Biohaven (NYSE:BHVN) with a Buy rating and set a price target of $57, indicating a positive outlook for the company's stock.
September 16, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies has initiated coverage on Biohaven with a Buy rating and a price target of $57, suggesting a positive short-term outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target by a reputable firm like Jefferies is likely to positively influence investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100